Please login to the form below

Not currently logged in
Email:
Password:

efficacy

This page shows the latest efficacy news and features for those working in and with pharma, biotech and healthcare.

Early ‘no’ for GW Pharma’s epilepsy drug, but NICE vows to collaborate

Early ‘no’ for GW Pharma’s epilepsy drug, but NICE vows to collaborate

Even though the committee accepted that the evidence shows that cannabidiol with clobazam reduces seizure frequency, its long-term efficacy is unknown, and the committee was not convinced about the way

Latest news

More from news
Approximately 2 fully matching, plus 1,622 partially matching documents found.

Latest Intelligence

  • The evolution of real-world studies The evolution of real-world studies

    Having cut their teeth using RWE to validate safety post-approval, companies are increasingly interested in using evidence of real- world efficacy to win approval in new indications, leading to landmark

  • Streamlining clinical trials – why better data use is key Streamlining clinical trials – why better data use is key

    championed the adoption of single IRBs for multicentre clinical trials.” She added that an sIRB for such studies can improve quality and efficacy.

  • Biotech profile: Tom Evans, CEO, Vaccitech.

    We need new flu vaccine products that enable long-term use and can increased efficacy in at-risk groups, such as the elderly and immunocompromised. Our VTP-100 vaccine has the ... The second development pathway is as an adjunct for seasonal vaccines to

  • Rare disease trials Q&A Rare disease trials Q&A

    The selection of appropriate biomarkers and treatment outcomes. The design of clinical trials that can generate substantial efficacy and safety data and motivate patients. ... The selection of appropriate endpoints is crucial to provide substantial

  • The trials and tribulations of rare opportunities The trials and tribulations of rare opportunities

    size. And drug developers should take every opportunity to understand how best to illustrate efficacy, according to Keefer. ... For any disease, the drug must show efficacy, and the number of patients needed will depend upon the size of the effect.

More from intelligence
Approximately 1 fully matching, plus 119 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 62 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics